14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.71 $5.77 Friday, 3rd May 2024 AUPH stock ended at $5.10. This is 1.35% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.94% from a day low at $5.09 to a day high of $5.55.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jan 19, 2022 $18.83 $19.25 $18.43 $18.54 2 464 400
Jan 18, 2022 $18.89 $19.93 $18.55 $18.57 2 436 300
Jan 14, 2022 $18.38 $19.77 $18.36 $19.71 2 712 800
Jan 13, 2022 $18.24 $20.35 $17.91 $18.75 5 259 800
Jan 12, 2022 $19.56 $19.95 $18.36 $18.39 2 409 000
Jan 11, 2022 $19.17 $19.90 $18.75 $19.56 2 510 500
Jan 10, 2022 $18.48 $19.30 $17.85 $19.22 2 867 100
Jan 07, 2022 $20.00 $20.01 $18.77 $18.84 2 749 300
Jan 06, 2022 $19.86 $20.35 $18.86 $20.04 2 471 300
Jan 05, 2022 $22.09 $22.29 $19.55 $19.60 3 852 600
Jan 04, 2022 $22.50 $22.65 $21.82 $22.25 2 254 237
Jan 03, 2022 $22.87 $23.42 $22.15 $22.48 2 115 334
Dec 31, 2021 $22.88 $24.00 $22.82 $22.87 2 293 513
Dec 30, 2021 $22.49 $23.22 $22.23 $22.78 1 971 884
Dec 29, 2021 $23.03 $23.10 $21.52 $22.49 2 639 913
Dec 28, 2021 $23.70 $24.45 $23.16 $23.33 1 789 358
Dec 27, 2021 $23.00 $23.91 $22.73 $23.91 1 832 103
Dec 23, 2021 $22.49 $23.50 $22.37 $23.05 1 774 495
Dec 22, 2021 $22.42 $23.00 $22.15 $22.69 1 846 939
Dec 21, 2021 $21.19 $22.70 $21.00 $22.55 4 072 287
Dec 20, 2021 $20.72 $21.40 $20.21 $21.06 3 346 122
Dec 17, 2021 $19.51 $22.14 $19.24 $20.98 6 535 816
Dec 16, 2021 $19.56 $20.00 $18.61 $19.67 2 664 127
Dec 15, 2021 $18.16 $20.10 $18.00 $19.87 3 425 857
Dec 14, 2021 $19.35 $19.47 $17.97 $18.01 6 124 064
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT